Ikena Oncology, Inc.
Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the tran…
Biotechnology
US, Boston [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Ikena Oncology, Inc. (IKNA) to it's peer group.
Peer Group
AVTE STTK RZLT FHTX KYMR ELYM CELC HOWL EWTX DSGN GLUE XLO ANEB NRIX STOK MNOV DBTX
Compare Together
Loading...